Nomura Holdings
ATOS icon

Nomura Holdings’s Atossa Therapeutics ATOS Stock Holding History

Nomura Holdings’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16
Closed -$13K – 1177
2016
Q2 		$13K Buy
+16
New +$13K ﹤0.01% 1204
2014
Q3 		– Sell
-5
Closed -$24K – 2753
2014
Q2 		$24K Buy
+5
New +$19.4K ﹤0.01% 2647

Other funds holding ATOS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MFW
Mosaic Family Wealth St. Louis, Missouri $384M AUM 21.14% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nomura Holdings's ATOS Position: Q3 2016 in Review

Nomura Holdings sold out of Atossa Therapeutics (ATOS) in Q3 2016, closing a stake of 16 shares — an estimated $13K sold.

Nomura Holdings first reported a position in ATOS in Q2 2014 and held it in 2 quarters. The position peaked at $24K in Q2 2014. 9 funds tracked by Wall St. Rank hold ATOS as of Q3 2016.

  • Nomura Holdings reported no remaining Atossa Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Nomura Holdings sold 16 Atossa Therapeutics shares in Q3 2016, an estimated $13K.
  • Nomura Holdings first reported a position in Atossa Therapeutics in Q2 2014 and held it in 2 quarters.
  • Nomura Holdings's Atossa Therapeutics position peaked at $24K in Q2 2014.
  • 9 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2016.

Based on Nomura Holdings's 13F filing for Q3 2016, filed 14 Nov 2016.